What is the recommended vaccination schedule for Rotarix (rotavirus vaccine) in a healthy infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rotarix Vaccination Schedule

Rotarix (RV1) is administered as a 2-dose oral series at 2 and 4 months of age, with strict age restrictions: the first dose must be given between 6 weeks and 14 weeks 6 days of age, and all doses must be completed by 8 months of age. 1, 2

Standard Dosing Schedule

  • Dose 1: Administer at 2 months of age (can be given as early as 6 weeks) 1
  • Dose 2: Administer at 4 months of age 1
  • Minimum interval between doses: 4 weeks 1, 2
  • Each dose volume: 1.5 mL administered orally directly into the infant's mouth 2

Critical Age Restrictions

These age limits are absolute and cannot be violated:

  • Minimum age for first dose: 6 weeks 1, 2
  • Maximum age for first dose: 14 weeks and 6 days (do NOT initiate vaccination at 15 weeks or older) 1, 2, 3
  • Maximum age for final dose: 8 months and 0 days 1, 2

The ACIP and AAP emphasize that vaccination should not be initiated for infants aged 15 weeks or older due to insufficient safety data on the first dose in older infants. 1 If an infant reaches 15 weeks without receiving the first dose, they have permanently aged out of eligibility and should not receive the vaccine series. 3

Co-administration with Other Vaccines

Rotarix may be administered simultaneously with all routine infant vaccines without interference: 1, 2

  • DTaP (diphtheria, tetanus, acellular pertussis) 1
  • Haemophilus influenzae type b (Hib) 1
  • Inactivated poliovirus vaccine (IPV) 1
  • Hepatitis B vaccine 1
  • Pneumococcal conjugate vaccine 1
  • Inactivated influenza vaccine (for infants ≥6 months) 1

Special Populations

Preterm Infants

  • Use chronological age from birth, not corrected gestational age 2, 4
  • Vaccinate on the same schedule as term infants if the infant is clinically stable 1
  • May vaccinate at discharge from NICU/nursery if age-eligible and clinically stable 1
  • If readmitted within 2 weeks after vaccination, institute contact precautions for 2-3 weeks post-vaccination due to vaccine virus shedding 1

Breastfed Infants

  • Follow the identical schedule as non-breastfed infants 1, 2
  • No feeding restrictions before or after vaccine administration 1
  • Vaccine efficacy is similar in breastfed and non-breastfed infants 1

Previous Rotavirus Infection

  • Complete the vaccination series even if the infant had documented rotavirus gastroenteritis, as natural infection provides only partial immunity 1

Minor Acute Illness

  • Administer vaccine to infants with mild gastroenteritis or upper respiratory infection, with or without fever 1

Interchangeability with RotaTeq

  • Complete the series with the same product (Rotarix) whenever possible 1
  • If the previous vaccine product is unknown or unavailable, continue with available product 1
  • If any dose was RotaTeq (RV5) or product is unknown, administer a total of 3 doses to complete the series 1
  • All doses must still be completed by 8 months of age regardless of product used 1

Common Pitfalls to Avoid

  • Do not attempt "catch-up" vaccination for infants who missed the age window—there is no catch-up schedule for rotavirus vaccines 2, 3
  • Do not use corrected age for preterm infants—always use chronological age from birth, which may cause some preterm infants to age out before being stable enough to vaccinate 2, 4
  • Do not defer vaccination because other routine vaccines are delayed—rotavirus vaccine has strict age cutoffs that cannot be extended 1
  • Do not start the series at 15 weeks or older—the infant has permanently aged out of eligibility 2, 3

Clinical Rationale

The strict age restrictions exist because Rotarix was studied only in infants who received the first dose by 14 weeks 6 days of age, with demonstrated efficacy of 85-96% against moderate-to-severe rotavirus gastroenteritis. 1, 5, 6 The age limits also minimize any theoretical risk of intussusception, which was associated with the previous rotavirus vaccine (RotaShield) when given to older infants. 5, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rotavirus Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rotavirus Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

RotaTeq Administration Schedule

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rotarix (RIX4414): an oral human rotavirus vaccine.

Expert review of vaccines, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.